A recent study indicated that decreased expression levels of GYS2 reduced glycogen and significantly correlated with metastasis and poor prognosis of the patients with HCC, GYS2 restricted HBV-Related HCC growth through negative feedback loop with p53 (Chen et al., 2019). Here, GYS2 is linked to hepatocellular carcinoma.